Dr. Jonathan Jackson directs CellzDirect�s in vitro drug metabolism studies, including cytochrome P450 induction, inhibition and reaction phenotyping studies. Dr. Jackson received his doctorate in molecular and cellular toxicology from North Carolina State University in a graduate partnership program with the National Institute of Environmental Health Sciences (NIEHS). He was a pre-doctoral research fellow in the Human Metabolism Section in the NIEHS Laboratory of Pharmacology and Chemistry, under the direction of Drs. Joyce Goldstein and Masahiko Negishi. Dr. Jackson�s dissertation focused on the role of nuclear receptors in the drug-induced transcriptional activation of cytochrome P450 enzymes. As a postdoctoral research fellow, Dr. Jackson investigated the effects of nonalcoholic fatty liver disease on drug metabolism and disposition at the University of Arizona, under Dr. Nathan Cherrington. |